Qiuming Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qiuming Yu has a total of 201 co-authors. Here are the top co-authors by number of shared publications:
- Erjin Zheng
Department of Chemical Engineering, University of Washington, Seattle, Washington 98195, United States
11 shared publications - Yuanze Xu
Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, United States
11 shared publications Shripathi Ramakrishnan
10 shared publicationsYugang Zhang
10 shared publications- Xiaoyu Zhang
Robert Frederick Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, New York 14853, United States
8 shared publications Xiaoyu Zhang
7 shared publications
Latest Publications
- 5 November 2026
- Published by Springer Nature in Nature Nanotechnology
- p. 1-14
Repurposed endogenous virus-like vesicles mediate dendritic cell long-range antigen presentation and T cell activation for enhanced cancer vaccination
Dendritic cells release extracellular vesicles (DEVs) that amplify antigen presentation while incorporating patient-derived, rapidly evolving antigens. By enriching peptide–major histocompatibility complex (MHC) and co-stimulatory ligands orders of magnitude above donor-cell levels, DEVs emerge as potent vesicle-vaccines, although efficacy remains limited by unclear mechanisms. Here we show that dendritic cells repurpose the virus-like retrotransposon-derived Arc gene to generate endogenous virus-like vesicles (VLVs) that predominantly carry peptide–MHC and high-density co-stimulatory ligands, intensifying and extending antigen presentation. Upon antigen exposure, Arc partners with endogenous envelope proteins to assemble VLVs that directly engage T cells and trigger intrinsic adjuvanticity via viral mimicry. DEVs lacking Arc failed to prime antigen-specific T cell responses, whereas Arc overexpression shifted DEVs toward VLVs that trafficked to lymphoid organs, drove rapid CD4-assisted priming and durable CD8-biased memory, suppressed melanoma, and prolonged survival. Our data reveal a viral-mimicry mechanism enabling long-range immune activation and support Arc+ VLVs as an antigen-agnostic vaccine for cancer immunotherapy.
- 5 November 2026
- Published by Springer Nature in Nature Nanotechnology
- p. 1-14
Repurposed endogenous virus-like vesicles mediate dendritic cell long-range antigen presentation and T cell activation for enhanced cancer vaccination
Dendritic cells release extracellular vesicles (DEVs) that amplify antigen presentation while incorporating patient-derived, rapidly evolving antigens. By enriching peptide–major histocompatibility complex (MHC) and co-stimulatory ligands orders of magnitude above donor-cell levels, DEVs emerge as potent vesicle-vaccines, although efficacy remains limited by unclear mechanisms. Here we show that dendritic cells repurpose the virus-like retrotransposon-derived Arc gene to generate endogenous virus-like vesicles (VLVs) that predominantly carry peptide–MHC and high-density co-stimulatory ligands, intensifying and extending antigen presentation. Upon antigen exposure, Arc partners with endogenous envelope proteins to assemble VLVs that directly engage T cells and trigger intrinsic adjuvanticity via viral mimicry. DEVs lacking Arc failed to prime antigen-specific T cell responses, whereas Arc overexpression shifted DEVs toward VLVs that trafficked to lymphoid organs, drove rapid CD4-assisted priming and durable CD8-biased memory, suppressed melanoma, and prolonged survival. Our data reveal a viral-mimicry mechanism enabling long-range immune activation and support Arc+ VLVs as an antigen-agnostic vaccine for cancer immunotherapy.
- 12 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (33) , 35861-35874
Molecular Design of Chiral Naphthalenediimide-Based Cations for Chiral One-Dimensional Metal Halide Semiconductors with Strong Chiroptical Activity and Amplified Charge Transport Ability
Chiral organic–inorganic metal halide semiconductors (MHSs) have emerged as promising materials for chiroptoelectronics, spintronics and ferroelectrics. However, commonly used chiral cations with nonconductive aliphatic and aromatic structures exhibit large energy gaps between the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) relative to those of the inorganic frameworks. This energy mismatch between the chiral spacer and the inorganic sublattice creates a barrier that hinders charge-carrier transport, leading to inefficient out-of-plane charge mobility and strong quantum confinement effects. To address this challenge, we design and synthesize chiral n-type naphthalenediimide (NDI)-based cations, (R)-2-(7-ethyl-1,3,6,8-tetraoxo-3,6,7,8-tetrahydrobenzo[lmn][3,8]phenanthrolin-2(1H)-yl)propan-1-aminium ((R)-NDIEPA+). We successfully tune the LUMO level of (R)-NDIEPA+ to align with that of the inorganic sublattice, and the resulting chiral one-dimensional (1D) (R-NDIEPA)PbI3 MHS demonstrates a type II band alignment that facilitates charge separation, as evidenced by quenched photoluminescence and transient absorption dynamics indicative of ultrafast charge transfer across the organic–inorganic interface. As a result, these materials demonstrate an approximately 7-fold enhancement in electron mobility compared to the chiral 1D MHS incorporating nonconductive aromatic cations. (R-NDIEPA)PbI3 also exhibits a strong circular dichroism (CD) signal, confirming effective chirality transfer from the organic cation to the inorganic framework. These findings underscore the importance of leveraging the electronic properties of chiral organic cations while preserving strong chiroptical activity, highlighting the potential of (R-NDIEPA)PbI3 for chiroptoelectronic applications such as circularly polarized light photodetectors and other spintronic devices.
- 12 August 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (33) , 35861-35874
Molecular Design of Chiral Naphthalenediimide-Based Cations for Chiral One-Dimensional Metal Halide Semiconductors with Strong Chiroptical Activity and Amplified Charge Transport Ability
Chiral organic–inorganic metal halide semiconductors (MHSs) have emerged as promising materials for chiroptoelectronics, spintronics and ferroelectrics. However, commonly used chiral cations with nonconductive aliphatic and aromatic structures exhibit large energy gaps between the highest occupied molecular orbital (HOMO) and the lowest unoccupied molecular orbital (LUMO) relative to those of the inorganic frameworks. This energy mismatch between the chiral spacer and the inorganic sublattice creates a barrier that hinders charge-carrier transport, leading to inefficient out-of-plane charge mobility and strong quantum confinement effects. To address this challenge, we design and synthesize chiral n-type naphthalenediimide (NDI)-based cations, (R)-2-(7-ethyl-1,3,6,8-tetraoxo-3,6,7,8-tetrahydrobenzo[lmn][3,8]phenanthrolin-2(1H)-yl)propan-1-aminium ((R)-NDIEPA+). We successfully tune the LUMO level of (R)-NDIEPA+ to align with that of the inorganic sublattice, and the resulting chiral one-dimensional (1D) (R-NDIEPA)PbI3 MHS demonstrates a type II band alignment that facilitates charge separation, as evidenced by quenched photoluminescence and transient absorption dynamics indicative of ultrafast charge transfer across the organic–inorganic interface. As a result, these materials demonstrate an approximately 7-fold enhancement in electron mobility compared to the chiral 1D MHS incorporating nonconductive aromatic cations. (R-NDIEPA)PbI3 also exhibits a strong circular dichroism (CD) signal, confirming effective chirality transfer from the organic cation to the inorganic framework. These findings underscore the importance of leveraging the electronic properties of chiral organic cations while preserving strong chiroptical activity, highlighting the potential of (R-NDIEPA)PbI3 for chiroptoelectronic applications such as circularly polarized light photodetectors and other spintronic devices.
- 19 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (8) , 6078-6092
Detection and Profiling of Neurodegenerative Disease-Related Extracellular Vesicles through Membrane and Cargo Proteins
Early and accurate diagnosis of neurodegenerative diseases such as Parkinson's disease (PD) remains challenging due to the lack of reliable biomarkers during presymptomatic or nonspecific stages. Extracellular vesicles (EVs) are promising biomarkers because they carry disease-specific proteins on their membrane and within their cargo. However, conventional protein analysis methods face challenges to rapidly analyze and profile these proteins. Here, we introduce a label-free surface plasmon resonance (SPR) biosensing platform that integrates neurotoxin-induced in vitro PD models with quantitative EV biomarker profiling across intact and lysed states. Wild-type (wEVs) and disease-mimicking EVs (dEVs) are derived from human SH-SY5Y cells exposed to MPP+ and 6-OHDA to represent early- and late-stage PD, respectively. The multiplexed SPR chip, optimized through mixed-SAM surface chemistry and controlled antibody surface coverage, enables simultaneous detection of general EV markers (CD81, NCAM) and disease-associated α-synuclein (α-syn) species, including monomeric, aggregated, and phosphorylated forms, with a detection limit of 5.0 × 106 EVs/mL. Intact-EV assays reveal stage-dependent α-syn remodeling, where MPP+ dEVs show 5-fold higher surface α-syn enrichment than wEVs, while 6-OHDA dEVs exhibit over 10-fold elevation of aggregated α-syn, signifying enhanced extracellular aggregation at advanced stages. Lysed-EV analysis uncovers progressive intravesicular accumulation, with aggregate-associated responses increasing by over an order of magnitude from wEVs to 6-OHDA dEVs. Normalization to the luminal marker Alix further reveals a continuous rise in α-syn/Alix ratios across PD progression. Collectively, these findings demonstrate that neurotoxic stress drives both surface externalization and luminal encapsulation of aggregated α-syn in a stage-resolved manner, establishing a quantitative, label-free strategy for profiling EV-associated biomarkers of PD progression.
- 19 February 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (8) , 6078-6092
Detection and Profiling of Neurodegenerative Disease-Related Extracellular Vesicles through Membrane and Cargo Proteins
Early and accurate diagnosis of neurodegenerative diseases such as Parkinson's disease (PD) remains challenging due to the lack of reliable biomarkers during presymptomatic or nonspecific stages. Extracellular vesicles (EVs) are promising biomarkers because they carry disease-specific proteins on their membrane and within their cargo. However, conventional protein analysis methods face challenges to rapidly analyze and profile these proteins. Here, we introduce a label-free surface plasmon resonance (SPR) biosensing platform that integrates neurotoxin-induced in vitro PD models with quantitative EV biomarker profiling across intact and lysed states. Wild-type (wEVs) and disease-mimicking EVs (dEVs) are derived from human SH-SY5Y cells exposed to MPP+ and 6-OHDA to represent early- and late-stage PD, respectively. The multiplexed SPR chip, optimized through mixed-SAM surface chemistry and controlled antibody surface coverage, enables simultaneous detection of general EV markers (CD81, NCAM) and disease-associated α-synuclein (α-syn) species, including monomeric, aggregated, and phosphorylated forms, with a detection limit of 5.0 × 106 EVs/mL. Intact-EV assays reveal stage-dependent α-syn remodeling, where MPP+ dEVs show 5-fold higher surface α-syn enrichment than wEVs, while 6-OHDA dEVs exhibit over 10-fold elevation of aggregated α-syn, signifying enhanced extracellular aggregation at advanced stages. Lysed-EV analysis uncovers progressive intravesicular accumulation, with aggregate-associated responses increasing by over an order of magnitude from wEVs to 6-OHDA dEVs. Normalization to the luminal marker Alix further reveals a continuous rise in α-syn/Alix ratios across PD progression. Collectively, these findings demonstrate that neurotoxic stress drives both surface externalization and luminal encapsulation of aggregated α-syn in a stage-resolved manner, establishing a quantitative, label-free strategy for profiling EV-associated biomarkers of PD progression.
- Open Access
- 19 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (48) , 44457-44467
Layer Number Dependence of Chirality and Spin Polarized Lifetime in Chiral 2D Halide Perovskites
Chiral metal halide perovskite semiconductors (CMHS) are fascinating semiconductors with unique chiroptical properties and spin-polarized charge transport. Achieving long spin lifetimes and high carrier mobility concurrently is essential to realize the true potential of CMHS in manipulating charge, spin, and light. While conventional monolayer n = 1 CMHS possess appreciable anisotropy factors of circular dichroism (gCD) and photoluminescence (glum), imparting chirality to quasi-2D CMHS (n > 1) with enhanced carrier mobilities is underexplored. Herein, we systematically investigate the layer number (n-value) dependence and emergent trade-offs in chiroptical properties, spin-relaxation times, and carrier mobilities in chiral quasi-2D (R/S-MPEA)2MAn-1PbnI3n+1 single crystals and thin films (R/S-MPEA: R/S-β-methylphenylethylammonium; MA: methylammonium; n = 1-3). Films with n = 2 exhibited the highest gCD of 8 × 10-3, an order of magnitude larger than their n = 1 and n = 3 counterparts. On the other hand, n = 3 films demonstrated enhanced spin lifetimes up to 15 ps along with increased carrier mobility up to 11.6 cm2 V-1 s-1. As a result, photodiode-type photodetectors based on n = 3 CMHS reveal high specific detectivity and superior discrimination of circularly polarized light, outperforming n = 1 and 2. These findings highlight the potential of quasi-2D CMHS as tunable, high-performance platforms with longer spin lifetime and diffusion length, enabling new functionalities.
- 19 November 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (48) , 44457-44467
Open AccessLayer Number Dependence of Chirality and Spin Polarized Lifetime in Chiral 2D Halide Perovskites
Chiral metal halide perovskite semiconductors (CMHS) are fascinating semiconductors with unique chiroptical properties and spin-polarized charge transport. Achieving long spin lifetimes and high carrier mobility concurrently is essential to realize the true potential of CMHS in manipulating charge, spin, and light. While conventional monolayer n = 1 CMHS possess appreciable anisotropy factors of circular dichroism (gCD) and photoluminescence (glum), imparting chirality to quasi-2D CMHS (n > 1) with enhanced carrier mobilities is underexplored. Herein, we systematically investigate the layer number (n-value) dependence and emergent trade-offs in chiroptical properties, spin-relaxation times, and carrier mobilities in chiral quasi-2D (R/S-MPEA)2MAn-1PbnI3n+1 single crystals and thin films (R/S-MPEA: R/S-β-methylphenylethylammonium; MA: methylammonium; n = 1-3). Films with n = 2 exhibited the highest gCD of 8 × 10-3, an order of magnitude larger than their n = 1 and n = 3 counterparts. On the other hand, n = 3 films demonstrated enhanced spin lifetimes up to 15 ps along with increased carrier mobility up to 11.6 cm2 V-1 s-1. As a result, photodiode-type photodetectors based on n = 3 CMHS reveal high specific detectivity and superior discrimination of circularly polarized light, outperforming n = 1 and 2. These findings highlight the potential of quasi-2D CMHS as tunable, high-performance platforms with longer spin lifetime and diffusion length, enabling new functionalities.
- Open Access
- 30 July 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
Advancing the synthesis strategy and interface modification for efficient perovskite quantum dot solar cells
Perovskite quantum dots (PeQDs), as a promising material for photovoltaics for their unique optoelectronic properties, has seen significant improvement in cell performance by the interplay of advanced synthetic strategies and interface modifications.
- 30 July 2025
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry A
Open AccessAdvancing the synthesis strategy and interface modification for efficient perovskite quantum dot solar cells
Perovskite quantum dots (PeQDs), as a promising material for photovoltaics for their unique optoelectronic properties, has seen significant improvement in cell performance by the interplay of advanced synthetic strategies and interface modifications.
- 20 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Optical Materials
- Vol. 3 (7) , 1499-1512
Achiral Cation-Induced Chirality Tuning in Cycloalkyl Chiral Cation-Based Quasi-1D and 2D Perovskites
- 20 June 2025
- Published by American Chemical Society (ACS) in ACS Applied Optical Materials
- Vol. 3 (7) , 1499-1512
Achiral Cation-Induced Chirality Tuning in Cycloalkyl Chiral Cation-Based Quasi-1D and 2D Perovskites
- Top Cited Papers
- 17 April 2025
- Published by Springer Nature in Nature Nanotechnology
- Vol. 20 (6) , 772-778
On-demand formation of Lewis bases for efficient and stable perovskite solar cells
In the fabrication of FAPbI3-based perovskite solar cells, Lewis bases play a crucial role in facilitating the formation of the desired photovoltaic α-phase. However, an inherent contradiction exists in their role: they must strongly bind to stabilize the intermediate δ-phase, yet weakly bind for rapid removal to enable phase transition and grain growth. To resolve this conflict, we introduced an on-demand Lewis base molecule formation strategy. This approach utilized Lewis-acid-containing organic salts as synthesis additives, which deprotonated to generate Lewis bases precisely when needed and could be reprotonated back to salts for rapid removal once their role is fulfilled. This method promoted the optimal crystallization of α-phase FAPbI3 perovskite films, ensuring the uniform vertical distribution of A-site cations, larger grain sizes and fewer voids at buried interfaces. Perovskite solar cells incorporating semicarbazide hydrochloride achieved an efficiency of 26.1%, with a National Renewable Energy Laboratory-certified quasi-steady-state efficiency of 25.33%. These cells retained 96% of their initial efficiency after 1,000 h of operation at 85 °C under maximum power point tracking. Additionally, mini-modules with an aperture area of 11.52 cm2 reached an efficiency of 21.47%. This strategy is broadly applicable to all Lewis-acid-containing organic salts with low acid dissociation constants and offers a universal approach to enhance the performance of perovskite solar cells and modules.
- 17 April 2025
- Published by Springer Nature in Nature Nanotechnology
- Vol. 20 (6) , 772-778
Top Cited PapersOn-demand formation of Lewis bases for efficient and stable perovskite solar cells
In the fabrication of FAPbI3-based perovskite solar cells, Lewis bases play a crucial role in facilitating the formation of the desired photovoltaic α-phase. However, an inherent contradiction exists in their role: they must strongly bind to stabilize the intermediate δ-phase, yet weakly bind for rapid removal to enable phase transition and grain growth. To resolve this conflict, we introduced an on-demand Lewis base molecule formation strategy. This approach utilized Lewis-acid-containing organic salts as synthesis additives, which deprotonated to generate Lewis bases precisely when needed and could be reprotonated back to salts for rapid removal once their role is fulfilled. This method promoted the optimal crystallization of α-phase FAPbI3 perovskite films, ensuring the uniform vertical distribution of A-site cations, larger grain sizes and fewer voids at buried interfaces. Perovskite solar cells incorporating semicarbazide hydrochloride achieved an efficiency of 26.1%, with a National Renewable Energy Laboratory-certified quasi-steady-state efficiency of 25.33%. These cells retained 96% of their initial efficiency after 1,000 h of operation at 85 °C under maximum power point tracking. Additionally, mini-modules with an aperture area of 11.52 cm2 reached an efficiency of 21.47%. This strategy is broadly applicable to all Lewis-acid-containing organic salts with low acid dissociation constants and offers a universal approach to enhance the performance of perovskite solar cells and modules.
- Open Access
- 20 March 2025
- Published by Springer Nature in Research Square
Repurposed endogenous virus-like vesicles mediate dendritic cell long-range antigen presentation and T-cell activation for enhanced cancer vaccination
Dendritic cells (DCs) can process patient-derived antigens to generate extracellular vesicles (DEVs) vaccines, which can be personalized and rapidly adapted to the evolving antigenic profile in chronic diseases. These DEVs present antigens and stimulate T cell responses, but their clinical efficacy is limited by poorly understood mechanisms. This study reveals how DCs incorporate ancient viral genes to produce endogenous virus-like vesicles (VLVs) that enable long-range T cell communication. Overexpressing a viral capsid protein Arc and a capsid-stabilizer substantially boosted DEVs’ antigen-presentation capabilities and immune responses, whereas Arc-deficient DEVs failed to generate specific immune memory. Proteomic analysis revealed that engineered virus-like vesicles (eraVLVs) enhance antigen presentation on MHC-I, recruit viral proteins for direct T cell interaction, and act as built-in adjuvants to boost broad immune responses. Using a cancer vaccine platform independent of model-specific antigens, we demonstrated robust and broad anti-cancer efficacy, with eraVLVs substantially extending median survival.
- 20 March 2025
- Published by Springer Nature in Research Square
Open AccessRepurposed endogenous virus-like vesicles mediate dendritic cell long-range antigen presentation and T-cell activation for enhanced cancer vaccination
Dendritic cells (DCs) can process patient-derived antigens to generate extracellular vesicles (DEVs) vaccines, which can be personalized and rapidly adapted to the evolving antigenic profile in chronic diseases. These DEVs present antigens and stimulate T cell responses, but their clinical efficacy is limited by poorly understood mechanisms. This study reveals how DCs incorporate ancient viral genes to produce endogenous virus-like vesicles (VLVs) that enable long-range T cell communication. Overexpressing a viral capsid protein Arc and a capsid-stabilizer substantially boosted DEVs’ antigen-presentation capabilities and immune responses, whereas Arc-deficient DEVs failed to generate specific immune memory. Proteomic analysis revealed that engineered virus-like vesicles (eraVLVs) enhance antigen presentation on MHC-I, recruit viral proteins for direct T cell interaction, and act as built-in adjuvants to boost broad immune responses. Using a cancer vaccine platform independent of model-specific antigens, we demonstrated robust and broad anti-cancer efficacy, with eraVLVs substantially extending median survival.
- 21 October 2024
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 40 (44) , 23473-23482
Enhancing mRNA Interactions by Engineering the Arc Protein with Nucleocapsid Domain
Activity-regulated cytoskeleton-associated protein (Arc) forms virus-like capsids for mRNA transport between neurons. Unlike HIV-1 Group-specific Antigen (Gag), which uses its Nucleocapsid (NC) domain to bind HIV-1 genomic mRNA, mammalian Arc lacks the NC domain, and their direct mRNA binding interactions remain underexplored. This study examined rat Arc's binding to rat Arc 5' UTR (A5U), HIV-1 5' UTR (H5U), and GFP mRNAs, revealing weak binding with no significant preference. Adding the HIV-1 NC domain to rArc's C-terminus significantly improved binding to H5U, while also showing substantial binding to A5U at about 60% of its H5U level and exhibiting twice the affinity for A5U over GFP mRNA. Importantly, rArc-NC binds 3.4 times more A5U and H5U than GST-NC, indicating that rArc NTD-CA aids mRNA binding by HIV-1 NC. These findings suggest a conserved Gag protein-mRNA interaction mechanism, highlighting the potential for developing mRNA delivery systems that combine endogenous Gag NTD-CA with retroviral NC and UTRs.
- 21 October 2024
- Published by American Chemical Society (ACS) in Langmuir
- Vol. 40 (44) , 23473-23482
Enhancing mRNA Interactions by Engineering the Arc Protein with Nucleocapsid Domain
Activity-regulated cytoskeleton-associated protein (Arc) forms virus-like capsids for mRNA transport between neurons. Unlike HIV-1 Group-specific Antigen (Gag), which uses its Nucleocapsid (NC) domain to bind HIV-1 genomic mRNA, mammalian Arc lacks the NC domain, and their direct mRNA binding interactions remain underexplored. This study examined rat Arc's binding to rat Arc 5' UTR (A5U), HIV-1 5' UTR (H5U), and GFP mRNAs, revealing weak binding with no significant preference. Adding the HIV-1 NC domain to rArc's C-terminus significantly improved binding to H5U, while also showing substantial binding to A5U at about 60% of its H5U level and exhibiting twice the affinity for A5U over GFP mRNA. Importantly, rArc-NC binds 3.4 times more A5U and H5U than GST-NC, indicating that rArc NTD-CA aids mRNA binding by HIV-1 NC. These findings suggest a conserved Gag protein-mRNA interaction mechanism, highlighting the potential for developing mRNA delivery systems that combine endogenous Gag NTD-CA with retroviral NC and UTRs.